Related Experiment Video
Updated: Dec 31, 2025

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
Identifying TF-miRNA-mRNA regulatory modules in nitidine chloride treated HCC xenograft of nude mice
Li Gao1, Dan-Dan Xiong1, Rong-Quan He2
1Department of Pathology, First Affiliated Hospital of Guangxi Medical University Nanning 530021, Guangxi Zhuang Autonomous Region, China.
Abstract:
Nitidine chloride (NC) has reported tumor suppressive activities for various human cancers, including hepatocellular carcinoma (HCC). Nevertheless, the pharmacological mechanism of NC on HCC has not previously been elucidated. SMMC7721 HCC cell lines, before and after the treatment of NC, were injected into nude mice for a subcutaneous tumor xenograft model. MiRNA and mRNA sequencing were performed for both control and treated xenograft tissues to further analyze differential expressed miRNAs (DEmiRNAs) and mRNAs (DEmRNAs). The ten most significant DEmiRNAs were selected for prediction of transcription factors (TFs) and target genes. We constructed an interconnected network composed of TFs the ten most significant DEmiRNAs, the 100 most significant DEmRNAs, and selected target genes from online programs. Hub genes chosen from a protein-to-protein interaction network of hub genes were validated by correlation analysis, expression analysis, and Kaplan-Meier survival analysis. The five most up-regulated miRNAs (hsa-miR-628-5p, hsa-miR-767-5p, hsa-miR-767-3p, hsa-miR-1257, and hsa-miR-33b-3p) and the five most down-regulated miRNAs (hsa-miR-378d, hsa-miR-136-5p, hsa-miR-451a, hsa-miR-144-5p, and hsa-miR-378b) were singled out from the DEmiRNAs. Functional annotations indicated that potential target genes of the top five up-regulated miRNAs were mainly clustered in molecular processes concerning epithelial-to-mesenchymal transition. Hub genes, such as ITGA6 and ITGB4, were validated as up-regulated in HCC; both IFIT2 and IFIT3 were revealed by Kaplan-Meier survival curves as good prognostic factors for HCC. In summary, the regulating axes of NC-DEmiRNAs-DEmRNAs and TFs-DEmiRNAs-DEmRNAs in HCC that were discovered in this study may shed light on the possible molecular mechanism of NC in HCC.
Insights
Nitidine chloride (NC) shows tumor suppressive effects in hepatocellular carcinoma (HCC). This study elucidates NC's mechanism by analyzing miRNA and mRNA changes in HCC, identifying key regulatory networks and prognostic factors like IFIT2 and IFIT3.
Area of Science:
- Oncology
- Molecular Biology
- Genomics
Background:
- Nitidine chloride (NC) exhibits tumor suppressive properties in various cancers, including hepatocellular carcinoma (HCC).
- The precise pharmacological mechanism of NC in HCC remains largely unelucidated.
- Understanding these mechanisms is crucial for developing novel therapeutic strategies.
Purpose of the Study:
- To elucidate the molecular mechanism of Nitidine chloride (NC) in hepatocellular carcinoma (HCC).
- To identify differentially expressed miRNAs (DEmiRNAs) and mRNAs (DEmRNAs) regulated by NC in HCC.
- To construct regulatory networks involving transcription factors (TFs), DEmiRNAs, and DEmRNAs in HCC.
Main Methods:
- A subcutaneous tumor xenograft model using SMMC7721 HCC cell lines in nude mice was established.
- MiRNA and mRNA sequencing were performed on xenograft tissues before and after NC treatment.
- Bioinformatic analyses, including network construction and protein-protein interaction analysis, were utilized to identify hub genes and regulatory axes.
Main Results:
- Five up-regulated miRNAs (e.g., hsa-miR-628-5p) and five down-regulated miRNAs (e.g., hsa-miR-378d) were identified.
- Potential target genes of up-regulated miRNAs were associated with epithelial-to-mesenchymal transition.
- Hub genes ITGA6 and ITGB4 were validated as up-regulated in HCC; IFIT2 and IFIT3 showed prognostic value.
Conclusions:
- The study identified novel regulatory axes (NC-DEmiRNAs-DEmRNAs and TFs-DEmiRNAs-DEmRNAs) potentially underlying NC's mechanism in HCC.
- Validated hub genes and prognostic factors provide insights into HCC pathogenesis and therapeutic targets.
- This research contributes to understanding NC's role in HCC and suggests potential biomarkers for patient outcomes.

